The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. From Wikipedia
Rollout is planned for the 2025-26 respiratory virus season under a new policy limiting COVID-19 boosters to high-risk groups.
